Blood Test to Monitor Esophageal Cancer After Surgery
Part of Cancer, Digestive system clinical trials.
This trial looks at whether a personalized blood test can detect cancer returning after surgery for esophageal cancer. It tests people who had chemoradiotherapy before surgery and still had some cancer remaining in the removed tissue. The goal is to use the blood test to catch any remaining or returning cancer early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of esophageal cancer (squamous cell) that is locally advanced and can be surgically removed.
- You received chemotherapy and radiation before surgery, with or without immunotherapy, and the tumor was not completely gone when the removed tissue was checked.
- You are healthy enough to receive immunotherapy after surgery (ECOG score of 0 or 1).
- You have stored tumor tissue and blood samples available for special DNA testing.
- Your doctor expects you to survive at least 6 months after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three medicines (immunotherapy plus two chemotherapy drugs) given before surgery to shrink esophageal cancer. The goal is to make the tumor smaller and easier to remove completely, potentially improving the chance of a cure.
This study looks at how the tumor's surroundings change when you receive a combination of chemotherapy and immunotherapy before surgery for esophageal squamous cell carcinoma. The goal is to understand if this treatment approach is effective and how the tumor reacts, which may help guide future care.
This trial tests a new approach for patients with a specific type of esophageal cancer that can be surgically removed. You would first receive a combination of an immunotherapy drug (adebrelimab) with chemotherapy and radiation, and then instead of immediate surgery, your doctor would monitor you closely to see if surgery is still needed. This may help some patients avoid surgery while keeping the cancer under control.
This trial studies whether adding chemotherapy after surgery for esophageal squamous cell cancer can reduce the chance the cancer returns. It focuses on people whose surgery removed cancerous lymph nodes and who are healthy enough to tolerate chemotherapy.
This study uses a simple blood test (called ctDNA) to look for tiny traces of cancer DNA. The goal is to see if this test can predict how well your treatment works, helping doctors tailor care for esophageal cancer.
This trial studies how well “liquid biopsy” blood tests can work in people with newly diagnosed, operable esophageal cancer. It may help doctors monitor the cancer and guide treatment planning alongside standard care.
Hear when a new Esophageal Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.